FDA OKs Abilify For Autism-linked Irritability
FDA OKs Bristol-Meyers' Abilify to treat irritability linked to autism in children, teens
07:27PM 11/20/09
Pfizer's Geodon Gets Expanded FDA Approval
Pfizer's bipolar disorder drug Geodon receives expanded FDA approval
02:15PM 11/20/09
Pfizer Gets FDA Approval For Intravenous Revatio
Pfizer receives FDA approval for intravenous version of high blood pressure drug Revatio
11:16AM 11/20/09
'Fast Money' Recap: Playing Defense
The trading panel discussed moves for a market that is shifting to the downside.
07:46PM 11/19/09
FDA Panel Backs Safety, Benefits Of Spiriva
FDA panel backs stronger benefit claims and safety profile for inhaler drug Spiriva
02:38PM 11/19/09
Moody's Gives Negative View On Pharma Credit
Moody's: credit ratings for drugmakers could be hurt as industry copes with expiring patents
01:15PM 11/19/09
Overbought, With Negative Divergences (RealMoney.com $)
The market is overbought, but a bit differently for both bears and bulls this time.
07:05AM 11/19/09
Pfizer to Begin Selling Generics in Japan
Pfizer plans to start selling generic drugs in Japan beginning in 2011, a spokesman said, according to reports.
12:39AM 11/19/09
FDA Panel Backs Pfizer's Enhanced Vaccine For Kids
FDA panel says next-generation anti-bacterial vaccine from Pfizer works for children
03:19PM 11/18/09
Vivus Shares Rise On Positive Avanafil Study Data
Vivus shares rise as erectable dysfunction drug avanafil meets late-stage study goal
11:55AM 11/18/09
Another Genzyme Drug Goes Kaboom: BioBuzz
Company halts development of kidney disease drug following poor test results.
08:05AM 11/18/09
Vivus Seeks Faster ED Drug: Biobuzz
Company says ED drug met all goals in phase III study.
06:42AM 11/18/09
Drugmakers' Differences: Analyst's Toolkit
Pharmaceutical companies require their own metrics of evaluation. Sanofi, which looks strong in some ways, comes across as risky in others.
05:00AM 11/18/09



Connect with TheStreet